Patients in Europe are waiting longer to access medicines than patients in the US, a new report warns. The European Federation of Pharmaceutical Industries and Associations (EFPIA)’s report shows 49% of FDA-approved medicines are not available in Europe, up from 46% in 2019. Data also indicates 17% of medicines are only available in Europe under […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!